GlobeNewswire·Nov 9, 2026, 4:05 PM ET

LifeVantage Announces Financial Results for the First Quarter Fiscal 2027

LFVN

LifeVantage reported first-quarter fiscal 2027 revenue of $37.1 million, a 22.0% decrease from the prior year period.
Revenue in the Americas decreased 22.2% to $29.0 million, while revenue in Asia/Pacific & Europe decreased 21.2% to $8.2 million.
The revenue decline was primarily driven by lower active accounts due to macroeconomic factors & reduced sales of the MindBody GLP-1 System, partially offset by LoveBiome product sales acquired in October 2025.
The company reported a net loss of $0.2 million, or $0.02 per diluted share, compared to net income of $2.2 million, or $0.17 per share, in the prior year.
Adjusted earnings per diluted share were $0.05, down from $0.18 a year ago, with adjusted EBITDA falling to $1.9 million from $3.9 million.
Gross profit decreased to $28.0 million (75.4% of revenue) due to a $1.0 million inventory obsolescence allowance for the MindBody GLP-1 System & increased shipping expenses.
Commissions & incentives expense totaled $15.4 million (41.4% of revenue), down from $20.7 million, reflecting changes in incentive programs & customer mix.
Selling, general & administrative expenses were $12.7 million, representing 34.3% of revenue compared to 31.2% in the prior year.
Cash generated from operations was $0.5 million for the quarter, contrasting with $2.3 million used in operations the prior year.
Cash & cash equivalents stood at $13.7 million as of September 30, 2026, with no debt outstanding.
The company held $58.5 million remaining under its $60 million share repurchase program, with no shares repurchased during the quarter.
Total active accounts declined 19.0% to 98,000, including a 16.7% drop in active independent consultants & a 20.5% drop in active customers.
LifeVantage announced a strategic shift toward a brand-driven, consumer-focused model supported by a modern digital platform & an expanded community of advocates.